(Q37977251)

26 August 2017

Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain (English)

1 reference

26 August 2017

Aarti N Patel

1

1 reference

PubMed ID

22261393

26 August 2017

Jack H Jhamandas

series ordinal

2

1 reference

26 August 2017

20 January 2012

1 reference

Expert Reviews in Molecular Medicine

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

e2

1 reference

Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.

26 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Role of insulin and insulin receptor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Cognition and synaptic plasticity in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

M1 receptors play a central role in modulating AD-like pathology in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Selective alpha7 nicotinic acetylcholine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Role of key aromatic residues in the ligand-binding domain of alpha7 nicotinic receptors in the agonist action of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Neuronal nicotinic receptors: a perspective on two decades of drug discovery research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Nicotinic Acetylcholine Receptors of Muscles and Nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The regulation of hippocampal LTP by the molecular switch, a form of metaplasticity, requires mGlu5 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid β peptide oligomers directly activate NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The concept of long term potentiation of transmission at synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

New life in an old idea: the synaptic plasticity and memory hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Sortilin is essential for proNGF-induced neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Long-Term Potentiation and Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

p75NTR is positively promiscuous: novel partners and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Alzheimer's disease amyloid beta-protein and synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Grasping objects: the cortical mechanisms of visuomotor transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Keeping track of neurotrophin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Structural and Functional Determinants of gamma-Secretase, an Intramembrane Protease Implicated in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Regulation of NMDA receptor trafficking by amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

RAGE: the beneficial and deleterious effects by diverse mechanisms of actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Actions of β-amyloid protein on human neurons are expressed through the amylin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Human amylin actions on rat cholinergic basal forebrain neurons: antagonism of beta-amyloid effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The role of amylin in the control of energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Pancreatic signals controlling food intake; insulin, glucagon and amylin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The role of APP processing and trafficking pathways in the formation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Incretin-based therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Requirement of α7 nicotinic acetylcholine receptors for amyloid β protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Alzheimer's disease: strategies for disease modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Beta-amyloid modulation of synaptic transmission and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Discovery of notch-sparing gamma-secretase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Secretase inhibitors and modulators for Alzheimer's disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

p75 reduces beta-amyloid-induced sympathetic innervation deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

NMDA receptor subunits: function and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Amyloid beta oligomers induce impairment of neuronal insulin receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Regulated secretion of beta-amyloid precursor protein in rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411002134

7 January 2021

10.1017/S1462399411002134

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22261393